Enoxolone
CAS No. 471-53-4
Enoxolone( Arthrodont | Biosone | Enoxolone | α-Glycyrrhetinic Acid? | GM 1658 | NSC 35347 | PO 12 | STX 352 )
Catalog No. M14567 CAS No. 471-53-4
Enoximone is a selective phosphodiesterase inhibitor with vasodilating and positive inotropic activity that does not cause changes in myocardial oxygen consumption.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 500MG | 39 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameEnoxolone
-
NoteResearch use only, not for human use.
-
Brief DescriptionEnoximone is a selective phosphodiesterase inhibitor with vasodilating and positive inotropic activity that does not cause changes in myocardial oxygen consumption.
-
DescriptionEnoximone is a selective phosphodiesterase inhibitor with vasodilating and positive inotropic activity that does not cause changes in myocardial oxygen consumption. It is used in patients with congestive heart failure. Trials were halted in the U.S., but the drug is used in various countries.
-
In Vitro——
-
In Vivo——
-
SynonymsArthrodont | Biosone | Enoxolone | α-Glycyrrhetinic Acid? | GM 1658 | NSC 35347 | PO 12 | STX 352
-
PathwayMetabolic Enzyme/Protease
-
TargetDehydrogenase
-
RecptorDHO
-
Research AreaOther Indications
-
Indication——
Chemical Information
-
CAS Number471-53-4
-
Formula Weight470.68
-
Molecular FormulaC30H46O4
-
Purity>98% (HPLC)
-
SolubilityDMSO: 94 mg/mL (199.71 mM)
-
SMILESCC(C)([C@](CC[C@@]([C@@]1(CC[C@]2(CC[C@](C(O)=O)(C[C@]2(C1=C3)[H])C)C)C)4C)5[H])[C@@H](O)CC[C@]5(C)[C@@]4([H])C3=O
-
Chemical Name(2S,4aS,6aS,6bR,8aR,10S,12aS,12bR,14bR)-10-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-2-carboxylic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Boldt J, et al. Expert Opin PharmacOthers. 2007, 8(13):2135-47.
molnova catalog
related products
-
IDH1-IN-1
Mutant IDH1-IN-1 is a potent mutant IDH1 R132H inhibitor with IC50 < 0.1 uM(A level in Patent).
-
GSK321
GSK321 is a selective and potent mutant isocitrate dehydrogenase 1 (IDH1) inhibitor that inhibits lipid synthesis and blocks cell proliferation in OPA1-deficient MEFs and prevents cytoplasmic glutamine reductive carboxylation.GSK321 has been used in the study of leukemia.
-
GSK1940029
GSK1940029 is a stearoyl-coa desaturase (SCD) inhibitor.
Cart
sales@molnova.com